See more : Cocrystal Pharma Inc (8CC1.DU) Income Statement Analysis – Financial Results
Complete financial analysis of Syra Health Corp. Class A Common Stock (SYRA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Syra Health Corp. Class A Common Stock, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Shinhan Financial Group Co., Ltd. (055550.KS) Income Statement Analysis – Financial Results
- Soprano Oyj (SOPRA.HE) Income Statement Analysis – Financial Results
- Kalray S.A. (ALKAL.PA) Income Statement Analysis – Financial Results
- Bridgeline Digital, Inc. (BLIN) Income Statement Analysis – Financial Results
- Kredyt Inkaso S.A. (KRI.WA) Income Statement Analysis – Financial Results
Syra Health Corp. Class A Common Stock (SYRA)
About Syra Health Corp. Class A Common Stock
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 5.52M | 5.62M | 1.41M | 0.00 |
Cost of Revenue | 4.10M | 4.56M | 979.62K | 0.00 |
Gross Profit | 1.41M | 1.06M | 430.35K | 0.00 |
Gross Profit Ratio | 25.60% | 18.90% | 30.52% | 0.00% |
Research & Development | 240.05K | 0.00 | 0.00 | 0.00 |
General & Administrative | 4.01M | 3.11M | 416.01K | 0.00 |
Selling & Marketing | 0.00 | 390.27K | 39.59K | 0.00 |
SG&A | 4.01M | 3.11M | 416.01K | 4.27K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 4.30M | 3.15M | 433.63K | 4.27K |
Cost & Expenses | 8.40M | 7.71M | 1.41M | 4.27K |
Interest Income | 2.94K | 63.00 | 0.00 | 0.00 |
Interest Expense | 53.69K | 28.53K | 0.00 | 0.00 |
Depreciation & Amortization | 48.77K | 14.85K | 207.00 | 51.20K |
EBITDA | -2.84M | -2.07M | -3.07K | -4.27K |
EBITDA Ratio | -51.42% | -36.93% | -0.22% | 0.00% |
Operating Income | -2.89M | -2.09M | -3.28K | -4.27K |
Operating Income Ratio | -52.36% | -37.20% | -0.23% | 0.00% |
Total Other Income/Expenses | -50.74K | -28.47K | 0.00 | -46.93K |
Income Before Tax | -2.94M | -2.12M | -3.28K | -4.27K |
Income Before Tax Ratio | -53.28% | -37.71% | -0.23% | 0.00% |
Income Tax Expense | 0.00 | 63.00 | 0.00 | -51.20K |
Net Income | -2.94M | -2.12M | -3.28K | -4.27K |
Net Income Ratio | -53.28% | -37.71% | -0.23% | 0.00% |
EPS | -0.60 | -0.36 | 0.00 | 0.00 |
EPS Diluted | -0.60 | -0.29 | 0.00 | 0.00 |
Weighted Avg Shares Out | 4.88M | 5.86M | 7.28M | 5.98M |
Weighted Avg Shares Out (Dil) | 4.88M | 7.28M | 7.28M | 5.98M |
Syra Health Announces Third Quarter 2023 Financial Results
Syra Health Launches SyraBot, a digital health product
Syra Health To Discuss Third Quarter 2023 Financial Results
Syra Health Secures Two-Year Contract to Assess and Implement Culturally and Linguistically Appropriate Services for Minnesota Department of Human Services
Syra Health (NASDAQ: SYRA) Rings The NASDAQ Opening Bell
Syra Health (Nasdaq: SYRA) to Ring The Nasdaq Stock Market Opening Bell on November 1
Syra Health and E&I Cooperative Services Announce New Agreement to Promote Syra's Mental Health Product known as "Syrenity"
Syra Health Announces the Launch of Syrenity, an AI-backed Mental Health Product for Organizations Offering Mental Health Workforce Solutions
Syra Health Announces the Launch of CarePlus, the Company's Electronic Medical Record System
Syra Health Secures Two-Year Extension of Indiana's Epidemiological Outcomes Workgroup Contract
Source: https://incomestatements.info
Category: Stock Reports